Bruce Booth has bought stock on 5 days since Feb 2018

Bruce Booth, DPhil, is a biotechnology investor and executive who serves as Chairman of the Board and Co‑Founder of Kymera Therapeutics, Inc. (NASDAQ: KYMR), where he has been a director since the company’s founding in September 2015.( As a Kymera director, Booth is reported in SEC filings and market reports as a corporate insider who has recently traded Kymera shares in his capacity as a member of the board of directors.( In addition to his role at Kymera, he is a partner at Atlas Venture, focusing on the discovery and development of novel medicines and therapeutic platforms, and has been a founding CEO or chairman of multiple biotechnology companies, including Nimbus Therapeutics and several other venture-backed firms.(

Booth’s broader career highlights include chairing or serving on the boards of numerous public and private biopharmaceutical companies, such as Vigil Neuroscience and Sionna Therapeutics, as well as earlier roles as a consultant at McKinsey & Company and an investor at Caxton Health Holdings.( He is also known for his long-running industry blog, LifeSciVC, where he writes about biotech and venture capital.( Booth holds a D.Phil. (PhD) in molecular immunology from Oxford University and a BS in biochemistry, summa cum laude, from The Pennsylvania State University.(

Written by Perplexity from public sources.